| | |
| Clinical data | |
|---|---|
| Drug class | Sirtuin-3 (SIRT3) activator |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C26H29I2N2O3 |
| Molar mass | 671.338 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
ADTL-SA1215 is a drug which acts as a sirtuin-3 (SIRT3) activator. It has been researched as a potential therapeutic agent for the treatment of triple negative breast cancer, as well as being used for basic research into the structure and function of the SIRT3 enzyme complex. [1] [2]